Related Experiment Videos
[Captopril in cardiac insufficiency. Immediate and long-term effects]
Archives Des Maladies Du Coeur Et Des Vaisseaux
|July 1, 1984
Summary
Captopril effectively reduced pulmonary capillary pressure and improved cardiac index in patients with heart failure. While initial hemodynamic improvements were noted, long-term effects on systemic blood pressure and resistance diminished over time.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Heart failure is a complex condition often refractory to standard digitalis-diuretic therapy.
- Assessing novel therapeutic agents is crucial for improving patient outcomes.
Purpose:
- To evaluate the hemodynamic effects of captopril in patients with cardiac failure resistant to conventional treatments.
- To determine the short-term and sustained efficacy of captopril in managing refractory heart failure.
Summary:
- Captopril administration in 23 heart failure patients demonstrated significant reductions in pulmonary capillary pressure, pulmonary artery pressure, and right atrial pressure.
- A single dose of captopril led to increased cardiac index and decreased pulmonary and systemic vascular resistance.
- While initial hemodynamic benefits were observed, long-term treatment showed a return to baseline for systemic blood pressure, heart rate, and systemic resistances, though pulmonary capillary pressure remained lower.
Impact:
- Captopril shows potential as a therapeutic option for refractory cardiac failure, particularly in improving pulmonary hemodynamics.
- The study highlights the need for careful monitoring of systemic effects and potential tachyphylaxis with long-term captopril use.
- Findings contribute to understanding captopril's role in managing complex heart failure patients and guiding treatment strategies.